You are here

Sustained Release Olanzapine

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43MH068925-01A1
Agency Tracking Number: MH068925
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
AURITEC PHARMACEUTICALS, INC. 2275 E FOOTHILL BLVD
PASADENA, CA 91107
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 THOMAS Smith
 (617) 461-6263
 TSMITH@AURITECPHARMA.COM
Business Contact
Phone: (626) 376-4070
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity associated with psychotic disorders by developing injectable long-acting formulations of olanzapine (Zyprexa/R), currently a leading atypical antipsychotic a

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government